Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

The findings from the new study, published in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring ...

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

both conventional and AI-assisted histology, suggest improvements in fibrosis in patients treated with icosabutate,” said Arun Sanyal, M.D., Director of the Stravitz-Sanyal Institute for Liver ...

The study demonstrates that pharmacological administration of FGF21 protects against MASH pathology at least ... therapeutic potential for treating liver fibrosis and MASH. More information ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

A key factor in the pathology of MASH is the ... found that Nwd1 −/− mice exhibited liver pathologies, including excessive lipid accumulation, fibrosis, and heightened ER stress, mirroring ...